Dr. Matt Brody receives the inaugural Pfizer Upjohn Early Career Research Professorship of Molecular Pharmacology
Please join the department in congratulating Dr. Matt Brody, Assistant Professor of Pharmacology and the Division of Cardiovascular Medicine in the Department of Internal Medicine, on his appointment as the inaugural Pfizer Upjohn Early Career Research Professor of Molecular Pharmacology!
Dr. Brody’s research program focuses on understanding the molecular basis of cardiac disorders, including heart failure and hypertrophy, with a specific focus on the role of novel posttranslational modifications such as palmitoylation, prenylation, and acylation. He has successfully established a well-funded and expertly staffed laboratory. He provides excellent mentorship to trainees and is an effective didactic teacher. He is establishing a national scientific reputation as a thought leader in cardiovascular pharmacology.
Congratulations, Dr. Brody!
Featured News & Stories
What should you know before starting a GLP-1?
Congratulations to Sondra Auerbach on her retirement!
University of Michigan Professional Nurse Council ratifies contract with University of Michigan Health
Mindful gift supports patient well-being
CRISPR acts as commander-in-chief for backup defenses in bacteria